| Pharmaceutical quality by design: principles and applications S Beg, MS Hasnain Academic Press, 2019 | 67 | 2019 |
| Pharmaceutical Glass Interactions: A Review of Possibilities SA Pillai, D Chobisa, D Urimi, N Ravindra J Pharm Sci Res 8 (2), 103-11, 2016 | 48 | 2016 |
| Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities YC Chen, SF Gad, D Chobisa, Y Li, Y Yeo Journal of controlled release 330, 438-460, 2021 | 35 | 2021 |
| Filters and Filtration: A Review of Mechanisms That Impact Cost, Product Quality and Patient Safety SA Pillai, D Chobisa, D Urimi, N Ravindra J. Pharm. Sci. Res. 8 (5), 271-278, 2016 | 24 | 2016 |
| Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach D Chobisa, K Patel, J Monpara, M Patel, P Vavia International journal of pharmaceutics 535 (1-2), 360-370, 2018 | 14 | 2018 |
| Engineering microenvironment of biodegradable polyester systems for drug stability and release control NU Khaliq, D Chobisa, CA Richard, MR Swinney, Y Yeo Therapeutic Delivery 12 (1), 37-54, 2021 | 10 | 2021 |
| Design of experiments for the development of injectable drug products D Chobisa Design of Experiments for Pharmaceutical Product Development: Volume II …, 2021 | 8 | 2021 |
| QbD-based development of pharmaceutical parenteral drug products: an overview D Chobisa Pharmaceutical Quality by Design, 151-172, 2019 | 5 | 2019 |
| Design of Experiments for Pharmaceutical Product Development: Volume II: Applications and Practical Case Studies S Beg Springer Nature, 2021 | 4 | 2021 |
| Sustained delivery of griseofulvin by polymeric microparticles for neovascular eye disease treatment D Chobisa, K Sishtla, TW Corson, Y Yeo Investigative Ophthalmology & Visual Science 62 (8), 199-199, 2021 | 2 | 2021 |
| Pharmaceutical formulations of griseofulvin for long-term ocular delivery Y Yeo, D Chobisa, TW Corson US Patent App. 18/012,589, 2023 | 1 | 2023 |
| Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy (Small 10/2024) D Chobisa, A Muniyandi, K Sishtla, TW Corson, Y Yeo Small 20 (10), 2470085, 2024 | | 2024 |
| Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy D Chobisa, A Muniyandi, K Sishtla, TW Corson, Y Yeo Small 20 (10), 2306479, 2024 | | 2024 |
| Sustained release griseofulvin microparticles offer long-term therapy for choroidal neovascularization in a preclinical model TW Corson, D Chobisa, A Muniyandi, Y Yeo Investigative Ophthalmology & Visual Science 64 (8), 932-932, 2023 | | 2023 |
| LONG-TERM LOCAL DELIVERY OF GRISEOFULVIN FOR TREATMENT OF OCULAR NEOVASULARIZATION D Chobisa Purdue University Graduate School, 2023 | | 2023 |
| Pharmaceutical Formulations of Griseofulvin for Long-term Ocular Delivery Y Yeo, D Chobisa, T Corson WO Patent WO/2021/262,916, 2021 | | 2021 |
| Development of Nanoparticle Formulation for Long-term Ocular Delivery of Griseofulvin for Treatment of Age-related Macular Degeneration D Chobisa, K Sishtla, TW Corson, Y Yeo Controlled Release Society (CRS) Annual Meeting and Exposition, 2020 | | 2020 |
| Are We Doing Justice to the ‘Quality by Design’? D Chobisa Acta Scientific Pharmaceutical Sciences 4 (3), 01-02, 2020 | | 2020 |
| Evaluation of the efficiency of the Interaction chamber and impact of Processing parameters of Microfluidizer on the Globule Size behavior of a model o/w Micro-emulsion System D Chobisa, D Urimi, D M. K., SA Pillai, HP Bhagwatwar AAPS Annual Meeting and Exposition, 2016 | | 2016 |
| Dual stent for tumor targeting and capturing circulating tumor cell (CTC): a novel approach to prevent metastasis K Patel, J Monpara, M Patel, S Ingle, D Chobisa, P Vavia Bioinvest- Association of Biotechnology Led Enterprises, 2014 | | 2014 |
Yoon YeoIndustrial and Molecular Pharmaceutics, Biomedical Engineering, Purdue UniversityVerified email at purdue.edu
